We are live on ! Find out more
FRLN

Freeline Therapeutics Holdings plc American Depositary Shares
FRLN

Delisted

FRLN was delisted on the 16th of February, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 15 → 0 (-15)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

100% less capital invested

Capital invested by funds: $12.6M → $0 (-$12.6M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 15

Holders
–
Holders Change
-15
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SP
Syncona Portfolio
Guernsey
-$9.33M
2
UBS Group
UBS Group
Switzerland
-$633K
3
BOCH
Blue Owl Capital Holdings
New York
-$552K
4
Morgan Stanley
Morgan Stanley
New York
-$545K
5
PCM
PenderFund Capital Management
British Columbia, Canada
-$509K
Name Holding Trade Value Shares
Change 		Change in
Stake
SP
1
Syncona Portfolio
Guernsey
– -$9.33M -1,466,507 Closed
UBS Group
2
UBS Group
Switzerland
– -$633K -99,358 Closed
BOCH
3
Blue Owl Capital Holdings
New York
– -$552K -86,654 Closed
Morgan Stanley
4
Morgan Stanley
New York
– -$545K -85,514 Closed
JP Morgan Chase
5
JP Morgan Chase
New York
– -$426K -67,053 Closed
PCM
6
PenderFund Capital Management
British Columbia, Canada
– -$509K -60,401 Closed
Renaissance Technologies
7
Renaissance Technologies
New York
– -$220K -34,460 Closed
HCA
8
Harbor Capital Advisors
Illinois
– -$129K -20,352 Closed
SFM
9
Sphera Funds Management
Israel
– -$105K -16,445 Closed
Northern Trust
10
Northern Trust
Illinois
– -$99.7K -15,659 Closed
4WM
11
49 Wealth Management
Texas
– -$98.9K -15,519 Closed
RhumbLine Advisers
12
RhumbLine Advisers
Massachusetts
– -$985 -155 Closed
GI
13
Gradient Investments
Minnesota
– -$637 -100 Closed
APC
14
Aspire Private Capital
North Carolina
– -$509 -80 Closed
Qube Research & Technologies (QRT)
15
Qube Research & Technologies (QRT)
United Kingdom
– -$25 -4 Closed

FRLN Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q1 2024, worth a combined $0 — down 100% from $12.6M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of FRLN and 0 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Syncona Portfolio, exiting entirely with an estimated $9.33M sold.

  • 0 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q1 2024, down from 15 in Q4 2023.
  • Funds reported $0 of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q1 2024 and 15 closed out, a net change of -15 holders.
  • The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q1 2024 was Syncona Portfolio, an estimated $9.33M sold.

Based on aggregated 13F filings for Q1 2024.